Atopic dermatitis: New therapeutic considerations
- 30 June 1991
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 24 (6), 1097-1101
- https://doi.org/10.1016/0190-9622(91)70165-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The role of antihistamines in atopic dermatitisJournal of Allergy and Clinical Immunology, 1990
- Spontaneous Release of Histamine from Basophils and Histamine-Releasing Factor in Patients with Atopic Dermatitis and Food HypersensitivityNew England Journal of Medicine, 1989
- Treatment of itching in atopic eczema with antihistamines with a low sedative profile.BMJ, 1989
- Mechanism f inhibitory action of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) in vitro: Effect of tranilast on the release of arachidonic acid and its metabolites.The Japanese Journal of Pharmacology, 1988
- Dermal Deposition of Eosinophil-Granule Major Basic Protein in Atopic DermatitisNew England Journal of Medicine, 1985
- Increased Plasma Histamine Concentrations after Food Challenges in Children with Atopic DermatitisNew England Journal of Medicine, 1984
- Mechanism of action of antipruritic drugs.BMJ, 1983
- Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitisJournal of Allergy and Clinical Immunology, 1983
- Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitisJournal of the American Academy of Dermatology, 1983
- Inhibition of hypersensitivity reactions by a new drug, N(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′)Journal of Allergy and Clinical Immunology, 1976